XML 44 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
OPERATING ACTIVITIES    
Net loss $ (7,634) $ (10,191)
Net earnings (loss) from discontinued operations 4,036 (685)
Net loss from continuing operations (11,670) (9,506)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,423 1,540
Stock-based compensation expense 553 1,023
Non-cash reversal of loss contingency (Note 11)   (4,089)
Non-cash reversal of restructuring accrual (Note 12)   (795)
Loss on disposal of property, plant and equipment   451
(Recovery) provision for bad debt expense (7) 280
Loss on reclassification on held for sale assets 722 1,323
Income tax receivable non-cash   (1,462)
Deferred income tax expense   2,432
Changes in operating assets and liabilities:    
Accounts receivable (2,377) (5,739)
Due from Zhenfa 5,385  
Income tax receivable   6,229
Inventories, net 2,171 (1,513)
Other current assets (3,795) (600)
Accounts payable 569 2,759
Accrued liabilities 1,589 (2,036)
Income taxes payable (437) 117
Other, net 1,383 (753)
Net cash used in continuing operations (4,491) (10,339)
Net cash provided by discontinued operations 9  
Total net cash used in operating activities (4,482) (10,339)
INVESTING ACTIVITIES    
Capital investments (2,354) (2,657)
Proceeds from sale of fixed assets   2,391
Net cash used in continuing operations (2,354) (266)
Total net cash used in investing activities (2,354) (266)
FINANCING ACTIVITIES    
Repurchase of common stock in tender offer   (24,042)
Tender offer fees   (2,387)
Special dividend (20)  
Deposit for share issuance   3,400
Share issuance fees (4) (1,605)
Proceeds from common stock issued under employee stock purchase plan 2 2
Net cash used in continuing operations (22) (24,632)
Total net cash used in financing activities (22) (24,632)
Effect of exchange rate changes on cash (135) (156)
Net Change in cash and cash equivalents (6,993) (35,393)
Cash and cash equivalents, beginning of period 16,552 58,173
Cash and cash equivalents, end of period $ 9,559 $ 22,780